DIFLUNISAL (diflunisal) by Merck & Co. is clinical pharmacology action dolobid is a non-steroidal drug with analgesic, anti-inflammatory and antipyretic properties. Approved for rheumatoid arthritis. First approved in 1996.
Drug data last refreshed 20h ago
CLINICAL PHARMACOLOGY Action Dolobid is a non-steroidal drug with analgesic, anti-inflammatory and antipyretic properties. It is a peripherally-acting non-narcotic analgesic drug. Habituation, tolerance, and addiction have not been reported. Diflunisal is a difluorophenyl derivative of salicylic…
Worked on DIFLUNISAL at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
The Effects Diflunisal on the Levels of BMS-986165 in Healthy Participants